Cargando…

Evaluation of a Pharmacist-Managed Nonsteroidal Anti-Inflammatory Drugs Deprescribing Program in an Integrated Health Care System

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat symptoms of chronic inflammatory diseases such as osteoarthritis and rheumatoid arthritis; however, they are also associated with various adverse effects, including gastrointestinal (GI) bleeding and renal harm. As...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rashid, Rezoana, Chang, Christopher, Niu, Fang, Deguzman, Lynn, Draves, Maisha, Awsare, Sameer, Hui, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391032/ https://www.ncbi.nlm.nih.gov/pubmed/32584681 http://dx.doi.org/10.18553/jmcp.2020.26.7.918

Ejemplares similares

Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older Adults: A Randomized Clinical Trial
por: Herrinton, Lisa J., et al.
Publicado: (2023)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

The role of pharmacists in deprescribing benzodiazepines: A scoping review
por: Ashkanani, Fatemah Zakariya, et al.
Publicado: (2023)

Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010)

Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022)

Topical nonsteroidal anti-inflammatory drugs
por: Bhat, Chirag, et al.
Publicado: (2023)

Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
por: Bhardwaj, Sonia, et al.
Publicado: (2022)

Patients’ attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists
por: Lukacena, Kaylee M., et al.
Publicado: (2022)

Implementation of pharmacist-led deprescribing in collaborative primary care settings
por: Trenaman, Shanna C., et al.
Publicado: (2022)

Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
por: Jeter, Joanne M., et al.
Publicado: (2011)

Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
por: Schoenberger, Scott D., et al.
Publicado: (2013)

Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
por: Ishiguro, Hitoshi, et al.
Publicado: (2014)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2017)

“I Think Deprescribing as a Whole Is a Gap!”: A Qualitative Study of Student Pharmacist Perceptions about Deprescribing
por: Springer, Sydney P., et al.
Publicado: (2022)

Design of predictive model to optimize the solubility of Oxaprozin as nonsteroidal anti-inflammatory drug
por: Alshehri, Sameer, et al.
Publicado: (2022)

Student Perspectives on the Pharmacist’s Role in Deprescribing Opioids: A Qualitative Study
por: Cernasev, Alina, et al.
Publicado: (2023)

Adverse drug reactions of nonsteroidal anti-inflammatory drugs
por: Wiwanitkit, Viroj
Publicado: (2011)

Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Preschool Children
por: Kidon, Mona Iancovici, et al.
Publicado: (2007)

Congenital nephrotic syndrome and nonsteroidal anti-inflammatory drugs
por: Aoun, B., et al.
Publicado: (2012)

Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
por: Russo, Andrea, et al.
Publicado: (2013)

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Clinical Management of Nonsteroidal Anti-inflammatory Drug Hypersensitivity
por: Sánchez-Borges, Mario
Publicado: (2008)

Acute nonsteroidal anti-inflammatory drug-induced colitis
por: Tonolini, Massimo
Publicado: (2013)

Lithium Toxicity in the Setting of Nonsteroidal Anti-Inflammatory Medications
por: Hassan, Syed, et al.
Publicado: (2013)

Risk of stroke associated with nonsteroidal anti-inflammatory drugs
por: Park, Ki, et al.
Publicado: (2014)

Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit–Risk
por: Moore, Robert Andrew, et al.
Publicado: (2014)

Nonsteroidal anti-inflammatory drug hypersensitivity in the Asia-Pacific
por: Thong, Bernard Yu-Hor
Publicado: (2018)

Reply to Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Seo, Kyoung-Woo, et al.
Publicado: (2017)

Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity
por: Yeung, Wan Yin Winnie, et al.
Publicado: (2020)

Nonsteroidal anti-inflammatory drugs and glucocorticoids in COVID-19
por: Ricciotti, Emanuela, et al.
Publicado: (2021)

Solubility Optimization of Loxoprofen as a Nonsteroidal Anti-Inflammatory Drug: Statistical Modeling and Optimization
por: Alqarni, Mohammed, et al.
Publicado: (2022)

Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk
por: Goldkind, Lawrence, et al.
Publicado: (2006)

Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs.
por: Kalf, G F, et al.
Publicado: (1989)

Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
por: Roth, Sanford H
Publicado: (2011)

Nonsteroidal anti-inflammatory drugs misleading the diagnosis of periapical abscess
por: Archana, J. P. Angeline, et al.
Publicado: (2012)

Nonsteroidal anti-inflammatory drug-induced acute ulcers in the colon
por: Katsanos, Konstantinos H., et al.
Publicado: (2011)

Nonsteroidal anti-inflammatory drugs in the treatment of low back pain
por: Kuritzky, Louis, et al.
Publicado: (2012)

Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity
por: Loh, Wenyin, et al.
Publicado: (2015)

Nonsteroidal Anti-inflammatory Drug Induced Thrombotic Thrombocytopenic Purpura
por: Oregel, Karlos Z, et al.
Publicado: (2013)

Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs
por: McGeer, Patrick L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_17cdiuv2tvibqom4ccpg3jriuo